Investor Overview At Gilead we are inspired by the opportunity to address unmet medical needs for patients living with life-threatening diseases around the world. Stock Quote Stock Quote Volume: Dec 18, 2018 5:17 PM EST Latest News December 10, 2018 Gilead Sciences Names Daniel O’Day Chairman and Chief Executive Officer December 4, 2018 China National Medical Products Administration Approves Descovy® (Emtricitabine, Tenofovir Alafenamide) for the Treatment of HIV-1 Infection December 4, 2018 China’s National Medical Products Administration Approves Harvoni® (Ledipasvir/Sofosbuvir) for Treatment of Chronic Hepatitis C Virus Genotype 1-6 View All Events Nov 27, 2018 at 9:30 AM EST Gilead Sciences at the Evercore ISI HealthCONx Conference Oct 25, 2018 at 4:30 PM EDT Third Quarter 2018 Gilead Sciences Earnings Conference Call Oct 25, 2018 at 4:30 PM EDT Third Quarter 2018 Gilead Sciences Earnings Conference Call View All
